Form 4: Cross Country Healthcare Director Venkat Bhamidipati Reports Stock Transactions

Director Venkat Bhamidipati reports acquisition and disposal of Cross Country Healthcare (CCRN) stock on June 1, 2024, including shares withheld for tax obligations.

Summary

• On June 1, 2024, Venkat Bhamidipati, a director of Cross Country Healthcare, Inc. (CCRN), reported transactions involving the company's common stock.
• Bhamidipati acquired 9,921 shares of common stock at $0, which are restricted shares vesting on June 1, 2025.
• Additionally, 2,150 shares were disposed of at a price of $15.12 to cover tax withholding obligations related to restricted stock that vested on June 1, 2024.
• Following these transactions, Bhamidipati directly owns 14,749 shares of CCRN common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of restricted shares is a positive sign, while the disposal for tax obligations is a standard procedure. Overall, it reflects normal corporate activity.

Positives

• The acquisition of 9,921 restricted shares indicates a continued investment and alignment with the company's future.

Negatives

• The disposal of 2,150 shares to cover tax obligations, while standard, reduces the overall shareholding.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of restricted shares in 2025 suggests a continued relationship between the director and the company.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their trading activities. This filing indicates standard compensation practices and tax obligation fulfillment.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in the director's holdings, but the overall effect is likely minimal.

Key Dates